TYSONS CORNER, VA--(Marketwired - Oct 6, 2014) - ScripsAmerica, Inc. (OTCBB: SCRC) today announced that the Company's managed specialty pharmacy reported $5,457,137 in approved orders during the month of September 2014. The pharmacy's September revenue represented a 12% increase over the previous month and increased its annual run rate to over $65 million.
"Since Scrips began managing Main Avenue Pharmacy six months ago, its sales revenue generated by filling the Company's prescriptions has steadily increased each month, reaching nearly $5.5 million in September. We expect the revenue from ScripsAmerica's specialty pharmacy operations to remain strong during the fourth quarter and potentially increase in 2015 as we continueto expand our presence in this market across the country," commented ScripsAmerica's CEO Bob Schneiderman.
About ScripsAmerica, Inc.
ScripsAmerica, Inc. is a supplier of prescription, OTC and nutraceutical drugs, delivering pharmaceutical products to a wide range of end users across the health care industry. End users include retail pharmacies, hospitals, long-term care facilities and government and home care agencies. For more information, visit www.ScripsAmerica.com.
Safe Harbor Statement
This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.